Search Result for : Pharma Industry

The Dollar Business Bureau A leading Indian pharmaceuticals company Aurobindo Pharma has said that it would widen its product portfolio in the American market while planning to enter new markets in the Europe, a part of the company’s growth strategy in the coming 3-4 years. In the US market, Aurobindo Pharma plans to widen its portfolio through faster growth in OTC, injectable and higher complexity products, the company said in a presentation to investors. However, in European market, the company plans to enhance its presence in new geographies like Czech Republic and Poland, in addition to strengthening its position in the existing markets of Germany, France, Spain, Netherlands and the UK. Aurobindo Pharma is the 6th largest generic company by volume in the US, ...

Sneha Gilada Bio Asia 2017, a global healthcare exhibition and conference, started on February 6, 2017, here in  Hyderabad. The three day event was inaugurated by the Telangana Governor ESL Narsimhan. Early into the second day of Bio Asia, packed halls witnessed eminent speakers from the pharma industry sharing their future vision for the global healthcare sector. The 14th edition of Bio Asia, as the theme suggests, was a platform for delegates, coming from more than 50 countries, to collaborate and leverage India's potential in achieving quality healthcare for billions all over the world. Dr. Paul Stoffels, Worldwide Chairman of Pharma, Johnson & Johnson(J&J) The must-attend event for any healthcare enthusiast saw participation from more than 800 corporates, and over 100 high-profile speakers. The morning session on February 7 had a special address from the likes of  Dr. Paul Stoffels, Worldwide Chairman ...

The Dollar Business BureauPresident-elect Donald Trump bashed global drug manufacturing companies for overpricing their drugs and warned that they will have to deal with more competitive bidding practices for federal contracts during his administration. Addressing his first press conference post-election, Trump said many companies were "getting away with murder" and that everything will change once he settles down in the White House. Several drug companies have been criticised in the recent past for excessive hike in their drugs prices. Dow component Pfizer (PFE) has witnessed the wrath of the Congress for overpricing its life-saving allergy medication EpiPen. Allergan (AGN) and Valeant (VRX) have also been criticised for raising drug prices. Trump's tough talk about drug prices has generated negative sentiments amongst investors, who ...

The Dollar Business Bureau  Indian pharma manufacturer Granules India said on Friday that it has got 11 observations from INFARMED - the health authority of Portugal, for its manufacturing unit situated at Gagillapur in the state of Telangana.  “INFARMED had conducted a renewal inspection of the facility. In this respect, the company has received the inspection report with 11 observations,” said Granules India in a regulatory filing.   INFARMED is a Government agency of Portugal accountable to the Health Ministry that evaluates, regulates, authorises, and controls health products as well as human medicines. The Gagillapur plant of the company manufactures finished dosages and pharmaceutical formulation intermediates (PFIs).  The Indian drug maker said that it has started taking necessary steps for addressing the observations of the Portuguese inspection agency and ...

The Dollar Business Bureau Indian MNC Sun Pharmaceuticals Industries Ltd and Israeli biotechnology company Moebius Medical have signed an exclusive international licensing agreement to further develop MM-II, a novel pharma candidate used in the treatment of osteoarthritis pain. “Sun Pharma and Israel-based Moebius Medical have entered into an exclusive worldwide licensing deal to further develop MM-II, a novel pharmaceutical candidate for the treatment of pain in osteoarthritis,” Sun Pharma said in a BSE filing. Commenting on the deal, Kirti Ganorkar, Global Head of Business Development, Sun Pharmaceuticals, said that the deal with Moebius Medical is a part of the company’s effort to create a branded product pipeline and improve the worldwide portfolio in pain medicines. We are motivated to further develop MM-II and are hoping to come up with new innovative treatments for patients suffering ...

The Dollar Business Bureau Jubilant Life Sciences, global pharma and life sciences major, has announced on Wednesday that it has got the final ANDA (Abbreviated New Drug Application) approval for generic drugs, used in the treatment for hypertension. “Jubilant Life Sciences has got final ANDA (Abbreviated New Drug Application) approval for Felodipine Extended-Release Tablets USP, 2.5 mg, 5 mg, and 10 mg, the generic version of Plendil Tablets of AstraZeneca, which is used for the treatment of hypertension,’ the company said in a statement. As of June 30 this year, the global pharmaceutical and life sciences company had an overall of 770 filings for Oral Solids, out of which 578 filings have been approved in several regions around the world. This consists of 70 ...

The Dollar Business Bureau Aurobindo Pharma on Monday announced that it has received the go-ahead from the US-based health regulator USFDA to manufacture and market its anti-infective Linezolid injection in the American market.  "The company has received final approval from the United States Food & Drug Administration (USFDA) to manufacture and market Linezolid injection, 600 mg/300 mL (2 mg/mL)," Aurobindo Pharma said in a statement. The company plans to launch the product during the second quarter of the current financial year. It has the generic version of Pharmacia & Upjohn Company's Zyvox injection in the same strength.   "The approved product has an estimated market size of $87 million for the twelve months ending June 2016 according to IMS," it said. This latest approval is Aurobindo Pharma’s 36th abbreviated new drug ...

The Dollar Business Bureau Central Board of Excise and Customs (CBEC) in association with Federation of Telangana and Andhra Pradesh Chambers of Commerce and Industry (FTAPCCI) organised an awareness programme on proposed Goods and Services Tax (GST) Law in Hyderabad on Monday. CBEC Special Secretary and Member Ram Tirath, senior officers of CBEC, Commercial Tax Department, and FTAPCCI members have shared their knowledge and clarified certain apprehensions of the trade and industry stake holders about the upcoming GST Law through this programme. Trading community in agri crops and commodities in Telangana and Andhra Pradesh operate through the system of commission agency. The agri commodities are currently taxed under the VAT law only upon sale. But, under Sec 3(2A) of the Model GST Law the transaction ...